VTEC O117:K1:H7. A new clonal group of E. coli associated with persistent diarrhoea in Danish travellers

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 4, 2005, Pages 288-294

  Olesen, Bente ^a,b   Jensen, Charlotte ^a   Olsen, Katharina E P ^a   Fussing, Vivian ^a   Gerner Smidt, Peter ^a   Scheutz, Flemming ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; MECILLINAM; METRONIDAZOLE; RESTRICTION ENDONUCLEASE; SULFONAMIDE; TINIDAZOLE; VEROTOXIN;

ADOLESCENT; ADULT; AFRICA; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM DETECTION; CHILD; CLINICAL ARTICLE; CUBA; DENMARK; DISEASE DURATION; ESCHERICHIA COLI; ESCHERICHIA COLI 0117; FEMALE; HUMAN; MALE; PATHOGENESIS; PERSISTENT INFECTION; PULSED FIELD GEL ELECTROPHORESIS; STRAIN DIFFERENCE; SYMPTOMATOLOGY; TRAVEL; TRAVELLER DIARRHEA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DENMARK; DIARRHEA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; TRAVEL;

EID: 17444432285     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410021090     Document Type: Article

References (43)

1. Bitzan M, Ludwig K, Klemt M, Konig H, Buren J, Mullerwiefel DE. The role of Escherichia coli O157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a central-European multicentre study. Epidemiol Infect 1993;110:183-96.
2. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohaemorrhagic E. coli, and the associated haemolytic syndrome. Epidemiol Rev 1991;13:60-98.
3. Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989;2:15-38.
4. Griffin PM, Mead PS, Sivapalasingam S. Escherichia coli O157:H7 and other enterohaemorrhagic Escherichia coli. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, editors. Infections of the gastrointestinal tract, 2nd edn. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 627-42.
5. Willshaw GA, Smith HR, Scotland SM, Rowe B. Cloning of genes determining the production of verocytotoxin by Escherichia coli. J Gen Microbiol 1985;131:3047-53.
6. Thomas A, Smith HR, Willshaw GA, Rowe B. Non-radioactively labelled polynucleotide oligonucleotide DNA probes for selectively detecting Escherichia coli strains producing verocytotoxins VT1, VT2 and VT2 variant. Mol Cell Probes 1991;5:129-35.
7. Venkatesan MM, Buysse JM, Kopecko DJ. Use of Shigella flexneri ipaC and ipaH gene sequences for the general identification of Shigella spp. and enteroinvasive Escherichia coli. J Clin Microbiol 1989;27:2687-91.
8. Sommerfelt H, Kalland KH, Raj P, Moseley SL, Bhan MK, Bjorvatn B. Cloned polynucleotide and synthetic oligonucleotide probes used in colony hybridization are equally efficient in the identification of enterotoxigenic Escherichia coli. J Clin Microbiol 1988;26:2275-8.
9. Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 1990;87:7839-43.
10. Kjaeldgaard P, Nissen B, Lange N, Laursen H. Evaluation of Minibact, a new system for rapid identification of Enterobacteriaceae. Comparison of Minibact, Micro-ID and API 20E with a conventional method as reference. Acta Pathol Microbiol Immunol Scand 1986;94:57-61.
11. Lautrop H, Høiby N, Bremmelgaard A, Korsager B. Bakteriologiske undersøgelsesmetoder, 1 ed. København: FADLs Forlag; 1979.
12. Kauffmann F. The bacteriology of Enterobacteriaceae, 2nd edn. (1969) Copenhagen: Munksgaard; 1966.
13. Ørskov F, Ørskov I. Serotyping of Escherichia coli. Meth Microbiol 1984;14:43-112.
14. Scheutz F. Verocytotoxin producing Escherichia coli (VTEC) isolated from Danish patients. 1-145. Own print. 1997. PhD thesis.
15. Beutin L, Montenegro MA, Ørskov I, Ørskov F, Prada J, Zimmerman S, et al. Close association of verotoxin (shiga-like toxin) production with enterohaemolysin production in strains of Escherichia coli. J Clin Microbiol 1989;27:2559-64.
16. Savarino SJ, McVeigh A, Watson J, Cravioto A, Molina J, Echeverria P, et al. Enteroaggregative Escherichia coli heatstable enterotoxin is not restricted to enteroaggregative E. coli. J Infect Dis 1996;173:1019-22.
17. Levine MM, Xu J-G, Kaper JB, Lior H, Prado V, Nataro J, et al. A DNA probe to identify enterohaemorrhagic Escherichia coli of O157:H7 and other serotypes that cause haemorrhagic colitis and haemolytic uraemic syndrome. J Infect Dis 1987;156:175-82.
18. Small PLC, Falkow S. Development of a DNA probe for the virulence plasmid of Shigella spp. and Enteroinvasive Escherichia coli. In: Leive L, Bonventre PF, Morello JA, Silver SD, Wu WC, Adam A, editors. Microbiology; 1986. p. 121-4.
19. Baudry B, Savarino SJ, Vial P, Kaper JB, Levine MM. A sensitive and specific DNA probe to identify entero-aggregative Escherichia coli, a recently discovered diarrhoeal pathogen. J Infect Dis 1990;161:1249-51.
20. Bilge SS, Clausen CR, Lau W, Moseley SL. Molecular characterization of a fimbrial adhesin F1845, mediating diffuse adherence of diarrhoea-associated Escherichia coli to HEp-2 cells. J Bacteriol 1989;171:4281-9.
21. Paton AW, Srimanote P, Woodrow MC, Paton JC. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect Immun 2001;69:6999-7009.
22. PulseNet USA. Standardized Molecular Subtyping of Food-borne Bacterial Pathogens by Pulsed-Field Gel Electrophoresis (Manual) Atlanta: CDC, National Center for Infectious Diseases; 2002.
23. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, Macdonald KL. Transmission of Escherichia coli 0157:H7 infection in Minnesota child day-care facilities. JAMA 1993;269:883-8.
24. Karch H, Rüssmann H, Schmidt H, Schwarzkopf A, Heesemann J. Long-term shedding and clonal turnover of enterohaemorrhagic Escherichia coli O157 in diarrhoeal diseases. J Clin Microbiol 1995;33:1602-5.
25. Pai CH, Gordon R, Sims HV, Bryan LE. Sporadic cases of haemorrhagic colitis associated with Escherichia coli 0157:H7. Clinical, epidemiological, and bacteriological features. Ann Intern Med 1984;101:738-42.
26. Shah S, Hoffman R, Shillam P, Wilson B. Prolonged faecal shedding of Escherichia coli O157:H7 during an outbreak at a day-care centre. Clin Infect Dis 1996;23:835-6.
27. Wells JG, Davis BR, Wachsmuth IK, Riley LW, Remis PS, Sokolow R, et al. Laboratory investigation of haemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol 1983;18:512-20.
28. Orr P, Milley D, Colby D, Fast M. Prolonged faecal excretion of verotoxin-producing Escherichia coli following diarrhoeal illness. Clin Infect Dis 1994;19:796-7.
29. Pai CH, Ahmed N, Lior H, Johnson WM, Sims HV, Woods DE. Epidemiology of sporadic diarrhoea due to verocytotoxin-producing Escherichia coli: a 2-y prospective study. J Infect Dis 1988;157:1054-7.
30. Nataro JP, Kaper JB. Diarrhoeagenic Escherichia coli. Clin Microbiol Rev 1998;11:142-201.
31. Stephan R, Schumacher S. Resistance patterns of non-O157 Shiga toxin-producing Escherichia coli (VTEC) strains isolated from animals, food and asymptomatic human carriers in Switzerland. Lett Appl Microbiol 2001;32:114-7.
32. Ratnam S, March SB, Ahmed R, Bezanson GS, Kasatiya S. Characterization of Escherichia coli serotype O157:H7. J Clin Microbiol 1988;26:2006-12.
33. Schroeder CM, Meng J, Zhao S, Debroy C, Torcolini J, Zhao C, et al. Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans. Emerg Infect Dis 2002;8:1409-14.
34. Coia JE. Nosocomial and laboratory-acquired infection with Escherichia coli O157. J Hosp Infect 1998;40:107-13.
35. Piérard D, van Etterijck R, Breynaert J, Moriau L, Lauwers S. Results of screening for verocytotoxin-producing Escherichia coli in faeces in Belgium. Eur J Clin Microbiol Infect Dis 1990;9:198-201.
36. Piérard D, Stevens D, Moriau L, Lior H, Lauwers S. Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples. Clin Microbiol Infect 1997;3:531-40.
37. Vila J, Vargas M, Ruiz J, Gallardo F, de Anta MTJ, Gascon J. Isolation of verotoxin-producing Escherichia coli O-rough:K1:H7 from 2 patients with travellers' diarrhoea. J Clin Microbiol 1997;35:2279-82.
38. Burnens AP, Boss P, Ørskov F, Ørskov I, Schaad UB, Muller F, et al. Occurrence and phenotypic properties of verotoxin producing Escherichia coli in sporadic cases of gastroenteritis. Eur J Clin Microbiol Infect Dis 1992;11:631-4.
39. Bettelheim KA, Whipp M, Djordjevic C, Hornitzky M. Biochemically atypical strains of Escherichia coli O117: H7 associated with severe adult diarrhoea. 2002. 10th International Congress of Bacteriology and Applied Microbiology, Paris, France.
40. Ethelberg S, Olsen KE, Scheutz F, Jensen C, Schiellerup P, Engberg J, et al. Virulence and patient risk factors associated with haemolytic uraemic syndrome and bloody diarrhoea among Danish patients with Shiga toxin-producing Escherichia coli. Emerg Infect Dis 2004;10:842-7.
41. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, et al. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 2003;41:4930-40.
42. Mølbak K, Mead PS, Griffin PM. Antimicrobial therapy in patients with Escherichia coli O157:H7 infection. JAMA 2002;288:1014-6.
43. Dupont HL. Travellers' diarrhoea. In: Blaser MJ, Smith BP, Ravdin JI, Greenberg HB, Guerrant RL, editors. Infections of the gastrointestinal tract, 2nd edn. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002. p. 253-65.